Erythrocin side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Erythrocin (erythromycin lactobionate). Common side effects include drug hypersensitivity among females and alanine aminotransferase increased among males.
The phase IV clinical study is created by eHealthMe based on 1,182 reports from the FDA, and is updated regularly.
What is Erythrocin?
Erythrocin has active ingredients of erythromycin lactobionate. It is often used in tooth abscess. eHealthMe is studying from 1,200 Erythrocin users. Check the latest studies of Erythrocin.
1,182 people who take Erythrocin and have side effects are studied.
What are the common side effects of Erythrocin, by gender? *
What are the common side effects of Erythrocin, by age (0-1 to 60+)? *
What are the common side effects of Erythrocin, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Erythrocin?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on erythromycin lactobionate (the active ingredients of Erythrocin) and Erythrocin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Erythrocin:
- Erythrocin (1,200 reports)
All Erythrocin side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Melatonin cause Primary Myelofibrosis? - 17 seconds ago
- Ovarian Cancer Recurrent and Metastases To Lymph Nodes - 17 seconds ago
- Singulair and Ferrous Fumarate drug interactions for women aged 60+ - 32 seconds ago
- Diabetic Neuropathy and Hypoglycaemia Aggravated - 33 seconds ago
- Hallucinations in Omeprazole, how severe and when it was recovered? - 34 seconds ago
- Lidocaine and Sweating - Excessive for Men aged 50-59 - 34 seconds ago
- Lidocaine and Perspiration - Excessive for Men aged 50-59 - 34 seconds ago
- Lidocaine and Diaphoresis for Men aged 50-59 - 34 seconds ago
- Lidocaine and Hyperhidrosis for Men aged 50-59 - 35 seconds ago
- Zanaflex and Urinary Incontinence for Men aged 30-39 - 44 seconds ago